Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NovaMedica Innotech is a specialized R&D and manufacturing center based in Moscow, Russia, operating as a subsidiary of NovaMedica. The facility focuses on the development of innovative drug delivery systems, particularly for oral solid dosage forms, including technologies for modified release and improved solubility. It offers comprehensive CDMO services, ranging from early-stage formulation development and analytical testing to the production of clinical trial materials and commercial-scale manufacturing. The center is a key component of the Technopolis Moscow Special Economic Zone and plays a vital role in the Russian pharmaceutical industry's efforts toward innovation and import substitution. Its capabilities include the creation of fixed-dose combinations and value-added medicines across therapeutic areas such as gastroenterology, neurology, and pain management.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NovaMedica Innotech.